- Home
- SMBC vs PSNL Comparison
SMBC vs PSNL Comparison
Compare SMBC & PSNL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SMBC
- PSNL
- Stock Information
- Founded
- SMBC 1887
- PSNL 2011
- Country
- SMBC United States
- PSNL United States
- Employees
- SMBC N/A
- PSNL N/A
- Industry
- SMBC Banks
- PSNL Medical Specialities
- Sector
- SMBC Finance
- PSNL Health Care
- Exchange
- SMBC Nasdaq
- PSNL Nasdaq
- Market Cap
- SMBC 587.7M
- PSNL 576.8M
- IPO Year
- SMBC N/A
- PSNL 2019
- Fundamental
- Price
- SMBC $56.65
- PSNL $6.59
- Analyst Decision
- SMBC Buy
- PSNL Strong Buy
- Analyst Count
- SMBC 3
- PSNL 5
- Target Price
- SMBC $66.33
- PSNL $8.00
- AVG Volume (30 Days)
- SMBC 42.0K
- PSNL 1.6M
- Earning Date
- SMBC 07-28-2025
- PSNL 08-06-2025
- Dividend Yield
- SMBC 1.62%
- PSNL N/A
- EPS Growth
- SMBC 8.53
- PSNL N/A
- EPS
- SMBC 4.99
- PSNL N/A
- Revenue
- SMBC $172,928,000.00
- PSNL $85,694,000.00
- Revenue This Year
- SMBC $15.25
- PSNL $0.45
- Revenue Next Year
- SMBC $6.17
- PSNL $25.75
- P/E Ratio
- SMBC $11.39
- PSNL N/A
- Revenue Growth
- SMBC 6.00
- PSNL 15.57
- 52 Week Low
- SMBC $43.10
- PSNL $1.14
- 52 Week High
- SMBC $68.69
- PSNL $7.20
- Technical
- Relative Strength Index (RSI)
- SMBC 67.19
- PSNL 69.33
- Support Level
- SMBC $53.61
- PSNL $6.27
- Resistance Level
- SMBC $56.95
- PSNL $7.03
- Average True Range (ATR)
- SMBC 1.50
- PSNL 0.43
- MACD
- SMBC 0.46
- PSNL 0.00
- Stochastic Oscillator
- SMBC 95.05
- PSNL 66.29
About SMBC Southern Missouri Bancorp Inc.
Southern Missouri Bancorp Inc is a USA-based holding company for Southern Missouri Savings Bank. The principal business of the bank consists of attracting retail deposits from the general public and using such deposits along with wholesale funding from the Federal Home Loan Bank of Des Moines, and to a lesser extent, brokered deposits, to invest in one- to four-family residential mortgage loans, mortgage loans secured by commercial real estate, commercial non-mortgage business loans, and consumer loans. It is engaged in providing the range of banking and financial services to individuals and corporate customers in its market areas. The company derives revenue principally from interest earned on loans, debt securities, bank card interchange fees, loan late charges and another fee income.
About PSNL Personalis Inc.
Personalis Inc is a provider of genomic sequencing and analytics solutions to support the development of personalized cancer vaccines and other next-generation cancer immunotherapies. It has one segment, the sale of sequencing and data analysis services. Its products include ImmunoID NeXT, NeXT Personal, NeXT Dx Test, and other pharma research solutions.